Stock Analiz

Healthcare Triangle, Inc. HCTI

EDP Services · IPO 2021 · data as of November 13, 2026

$3.66Market cap $3M
Open the interactive analysis →

Healthcare Triangle, Inc. (HCTI) is a technology company listed in the US with a market value of about $3M. In the twelve months to September 30, 2026 it had revenue of $31M and net income of -$18M, a net margin of -56.4%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of -15% a year, a 5-year average ROIC of -84%.

About Healthcare Triangle

Healthcare Triangle is listed in the US and classified in edp services, IPO year 2021. Revenue went from $31M in 2020 to $14M in 2025, a decline of about 15.0% a year. It was profitable in 1 of the last 6 years in our data. Its share count rose by 24914% over three years (dilution for shareholders). It spends 4% of revenue on research and development.

Score: 0.6 / 5

Value0/5
Future growth1/5
Track record0/5
Financial health1/5
Shareholder returns1/5

Checks passed

  • Revenue growth above 10% last year
  • Liabilities below 60% of assets
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.1
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-509.4%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)18.8%
Revenue growth (5 yrs, per year)-15.0%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-38.7%
ROIC (5-yr avg.)-84.0%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 6 years

Fiscal yearTTM202520242023202220212020
Revenue$31M$14M$12M$33M$46M$35M$31M
Net income-$18M-$9M-$6M-$9M-$14M-$6M$2M
Free cash flow—-$17M—-$2M-$5M-$7M—
EPS (diluted)$-19.02$-10.15$-1127.29$-2073.44$-3867.76$-201.36$83.73
Net margin-56.4%-68.2%-51.0%-26.2%-31.3%-16.9%7.5%
ROIC—-24.8%-0.4%-243.8%-125.4%-25.5%20.9%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 1 analysts is $63.00, 1621% above the current price; targets range from $63.00 to $63.00; the consensus rating is “none”; expected EPS is $-204.60 for the fiscal year ending December 31, 2026.

Frequently asked questions

Does Healthcare Triangle pay a dividend?

Not currently.

Is Healthcare Triangle a good stock to buy?

We do not give buy or sell advice. Healthcare Triangle scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.